Full Text View
Tabular View
No Study Results Posted
Related Studies
TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
This study has been completed.
Study NCT00077142   Information provided by M.D. Anderson Cancer Center
First Received: February 10, 2004   Last Updated: August 19, 2010   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Study Completion Date: August 2005
  Primary Completion Date: July 2005 (Final data collection date for primary outcome measure)
Publications:
Higginbotham KB, Lozano R, Brown T, Patt YZ, Arima T, Abbruzzese JL, Thomas MB. A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma. J Cancer Res Clin Oncol. 2008 Dec;134(12):1325-35. Epub 2008 May 27.




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services